Skip Navigation

Salud: Integrar la medicina tradicional y moderna

Noticias

  • Imprimir
  • Comentar

Brazil gets new drug based on local knowledge

Fuente: Revista da Fapesp

10 may 2005 | EN

A native plant known as maria-milagrosa ('Mary-miracle') is the base of a new anti-inflammatory which has just received the approval of the Brazilian agency of health vigilance. The drug is expected to be for sale in drugstores within six months. 

It will be launched as a cream and under the tradename Acheflan. According to José Roberto Lazzarini, director of research and development at Aché, the company that developed it, Acheflan will be the first topical anti-inflammatory prepared from maria-milagrosa, whose latin name is Cordia verbenacea.

According to Lazzarini, there are other plant based anti-inflammatory drugs on the market, but these are prepared with plants from abroad, for example from African countries.

Reynaldo Jesus-Garcia Filho, a researcher at the Federal University of São Paulo, says that clinical trials demonstrated that Acheflan is as effective and safe as the current drug, when used treat chronical tendinitis and persistent muscular pains. Studies showed that Acheflan causes fewer side-effects.  

The herb has traditionally used been used by Brazilians to make medicinal infusions, often sold in fairs.

Link to the full article in Revista da Fapesp (in Portuguese)

AGREGUE SU COMENTARIO

Esta es su red: comparta sus opiniones sobre cualquiera de nuestros artículos agregando sus comentarios.

Usted debe registrarse para enviar un comentario o para escribir a un autor que haya aceptado recibir comentarios. Por favor entrarsuscribirse.

Todos los comentarios están sujetos a revisión. Nos reservamos el derecho de editar los comentarios que contengan un lenguaje inapropiado o inadecuado. SciDev.Net mantiene los derechos de autor de todo el material que se publica en el portal. Por favor lea las condiciones de uso para más detalles.

Todo el material de SciDev.Net se puede reproducir gratuitamente siempre que se de crédito a la fuente y al autor. Para más detalles ver Creative commons.

Volver Noticias
Subir